# US 2026/0167782 A1 · Method for deacetylation of biopolymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0167782 A1
- Document ID: US20260167782A1
- Status: Published application
- Kind: A1
- Application number: 19/465,973
- Filed: 2026-01-30
- Published: 2026-06-18
- Earliest claimed: 2015-12-29
- Assignees: Galderma Holding SA
- Applicants: Galderma Holding SA
- Inventors: Johan Olsson; Craig Harris
- Web page: https://patentgrep.com/patent/US20260167782A1

## CPC

- C08J 3/075: Macromolecular gels
- A61K 8/042: {Gels}
- A61K 8/73: Polysaccharides
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 31/738: Cross-linked polysaccharides
- A61P 17/00: Drugs for dermatological disorders
- A61Q 19/00: Preparations for care of the skin
- C07C 209/62: by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds (C07C209/24 takes precedence)
- C07C 213/00: Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C 269/06: by reactions not involving the formation of carbamate groups
- C07F 7/083: {Syntheses without formation of a Si-C bond}
- C08B 37/0063: {Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan}
- C08B 37/0069: {Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof}
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- C08J 3/24: Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K)
- C08J 7/14: with acids, their salts or anhydrides
- C08K 5/09: Carboxylic acids; Metal salts thereof; Anhydrides thereof
- C08L 5/00: Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C07C 2603/18: Fluorenes; Hydrogenated fluorenes
- C08J 2305/00: Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.

## Claims

### Claim 1

A method of deacetylating a glycosaminoglycan, the method comprising contacting glycosaminoglycans with a hydroxylamine salt to produce at least partially deacetylated glycosaminoglycans.

### Claim 2 (depends on 1)

The method of claim 1, wherein the hydroxylamine salt is formed by hydroxylamine and an acid.

### Claim 3 (depends on 2)

The method of claim 2, wherein the acid is selected from mineral acids, organic acids, and mixtures thereof.

### Claim 4 (depends on 3)

The method of claim 3, wherein the mineral acids are selected from the group consisting of: sulfuric acid, hydrochloric acid, hydroiodic acid, hydrobromic acid, phosphoric acid, and mixtures thereof.

### Claim 5 (depends on 3)

The method of claim 3, wherein the organic acids selected from the group consisting of: acetic acid, propionic acid, pivalic acid, citric acid, oxalic acid, malonic acid, lactic acid, benzoic acid, halogenated carboxylic acids, and mixtures thereof.

### Claim 6 (depends on 3)

The method of claim 3, wherein the acid comprises hydroiodic acid.

### Claim 7 (depends on 3)

The method of claim 3, wherein the acid comprises trifluoroacetic acid.

### Claim 8 (depends on 1)

The method of claim 1, wherein the glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin, chondroitin sulfate, and mixtures thereof.

### Claim 9 (depends on 8)

The method of claim 8, wherein the glycosaminoglycan comprises hyaluronic acid.

### Claim 10 (depends on 1)

The method of claim 1, wherein the deacetylating is performed using a solution comprising:
the glycosaminoglycans; and
the hydroxylamine salt at a concentration of 0.01 M to 10 M.

### Claim 11 (depends on 10)

The method of claim 10, wherein the hydroxylamine salt is present at a concentration of 0.1 M to 5 M.

### Claim 12 (depends on 1)

The method of claim 1, wherein the deacetylating is performed at a temperature from 10° C. to 90° C.

### Claim 13 (depends on 1)

The method of claim 1, wherein the deacetylating is performed at a temperature from 70° C. to 90° C.

### Claim 14 (depends on 1)

The method of claim 1, wherein the deacetylating is performed for a time from 5 minutes to 200 hours.

### Claim 15 (depends on 1)

The method of claim 1, wherein the deacetylating is performed for a time from 5 minutes to 29 hours.

### Claim 16 (depends on 1)

The method of claim 1, wherein the deacetylating is performed at a pH of 4 to 9.

### Claim 17 (depends on 1)

The method of claim 1, wherein the at least partially deacetylated glycosaminoglycans produced in (a) have a degree of acetylation of 99% or less.

### Claim 18 (depends on 1)

The method of claim 1, wherein the at least partially deacetylated glycosaminoglycans produced in (a) have a degree of acetylation of 96% or less.

### Claim 19 (depends on 1)

The method of claim 1, wherein the deacetylating in (a) causes a reduction in molecular weight of the glycosaminoglycans of 90% or less.

### Claim 20 (depends on 1)

The method of claim 1, wherein a weight average molecular weight of the at least partially deacetylated glycosaminoglycans is at least 10% of the weight average molecular weight of the glycosaminoglycan before the deacetylating.
